Literature DB >> 26629225

Complete response after chemotherapy and radiotherapy of a tonsillar histiocytic sarcoma with regional lymph node involvement: a case report and review of the literature.

Xingxing Chen1, Li Zhang1, Jian Wang2, Yajia Gu3, Jeffrey Tuan4, Xuejun Ma1, Xiaonan Hong5, Xiaoli Yu1, Xiaomao Guo1.   

Abstract

We describe a case of tonsillar histiocytic sarcoma (HS) with regional lymph node involvement and complete response after multi-disciplinary therapy. Immunohistochemistry showed strong positive tumor staining for CD 68, and negative staining for CD20, CD45R0 and CD30 and non-cohesive proliferation of neoplastic histiocytes. Systemic chemotherapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOP-E) chemotherapy followed by radiotherapy was delivered to the patient. No evidence of recurrent disease existed on regular follow up three years later. The diagnostic methods and the practical treatment solutions are discussed here. We believe that although HS has been regarded as a potentially fatal disease entity, there remain some cases that do not pursue such an aggressive clinical course.

Entities:  

Keywords:  Histiocytic sarcoma; chemotherapy; radiotherapy; survival outcome; tonsillar

Year:  2015        PMID: 26629225      PMCID: PMC4659113     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  14 in total

1.  Primary intramedullary histiocytic sarcoma.

Authors:  Gentian Toshkezi; Faramarz Edalat; Carl O'Hara; Ivana Delalle; Lawrence S Chin
Journal:  World Neurosurg       Date:  2011-01-12       Impact factor: 2.104

Review 2.  Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.

Authors:  Usama Gergis; Hendrik Dax; Ellen Ritchie; Rachel Marcus; Usama Wissa; Attilio Orazi
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

3.  Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163.

Authors:  Jeffrey A Vos; Susan L Abbondanzo; Carol L Barekman; Joann W Andriko; Markku Miettinen; Nadine S Aguilera
Journal:  Mod Pathol       Date:  2005-05       Impact factor: 7.842

4.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

5.  Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.

Authors:  Jason L Hornick; Elaine S Jaffe; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

6.  [Cutaneous histiocytic sarcoma: report of one case].

Authors:  Katty Schnettler; Claudia Salomone; José R Valbuena
Journal:  Rev Med Chil       Date:  2009-06-25       Impact factor: 0.553

7.  A case of primary histiocytic sarcoma arising from thyroid gland.

Authors:  Lu Yu; Shou Jing Yang
Journal:  Pathol Oncol Res       Date:  2009-08-05       Impact factor: 3.201

8.  Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.

Authors:  Muneer H Abidi; Isaacson Tove; Rami B Ibrahim; Dan Maria; Edward Peres
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

9.  Primary histiocytic sarcoma of the spleen associated with hemophagocytosis.

Authors:  Koji Oka; Hirokazu Nakamine; Kunihiko Maeda; Mitsunori Yamakawa; Hiroshi Imai; Kohei Tada; Motohiro Ito; Yasuyuki Watanabe; Hikoji Suzuki; Makoto Iwasa; Isao Tanaka
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

10.  The two varieties of lymphoid tissue "reticulosarcomas", histiocytic and histioblastic types.

Authors:  G Mathé; R Gerard-Marchant; J L Texier; J R Schlumberger; L Berumen; M Paintrand
Journal:  Br J Cancer       Date:  1970-12       Impact factor: 7.640

View more
  2 in total

Review 1.  An advanced case of gastric histiocytic sarcoma treated with chemotherapy and gastrectomy: a case report and review of literature.

Authors:  Ryu Matsunaga; Yoshikazu Kanazawa; Kunihiko Matsuno; Daisuke Kakinuma; Taichiro Tokura; Atsushi Marumo; Shunsuke Yui; Fumihiko Ando; Yuka Masuda; Nobutoshi Hagiwara; Tsutomu Nomura; Shunji Kato; Toshiro Yoshiyuki; Yukako Domoto; Takashi Sakatani; Ryuji Ohashi; Koiti Inokuchi; Hiroshi Yoshida
Journal:  Clin J Gastroenterol       Date:  2021-06-08

2.  Case Report: Long-Term Response to Radiotherapy Combined With Targeted Therapy in Histiocytic Sarcoma Harboring Mutations in MAPK and PI3K/AKT Pathways.

Authors:  Zijian Liu; Yin Xiao; Xinxiu Liu; Qiuhui Li; Tao Liu; Fang Zhu; Gang Wu; Liling Zhang
Journal:  Front Oncol       Date:  2021-12-06       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.